Molecular docking studies were conducted to evaluate the interactions between fatty acid amides (FAAs) and cannabinoid receptors CB1 and CB2, both of which are relevant in breast cancer due to their role in tumor progression and the endocannabinoid system. The gene discussed is CNR1; the disease is breast cancer.